Metastatic uveal melanoma commonly spreads to the liver, and percutaneous hepatic perfusion can help control tumors within ...

HealthDay News — For patients with asthma, receipt of immune checkpoint inhibitor (ICI) therapy for melanoma or renal cell carcinoma is not associated with an increased risk for exacerbations, ...

A groundbreaking study from Tata Memorial Hospital shows that using ultra-low doses of nivolumab, an immunotherapy drug, can effectively treat cancer while drastically reducing costs by 90%. This ...

Breakthrough immunotherapy trials are showing unprecedented responses in a subset of rectal cancer patients, hinting at a ...

This March, join the Alliance for Clinical Trials in Oncology (Alliance) and the Alliance Foundation Trials (AFT) in spotlighting colorectal cancer, the second leading cause of cancer-related death in ...

Mumbai: A new study from the Tata Memorial Centre has highlighted that many modern cancer medicines, especially immunotherapy ...

Delcath Systems, Inc. , ("Delcath" or the "Company") an interventional oncology company focused on the treatment of primary and metastatic liver cancers, today announced the publication of the full ...

Experts explain stage IV lung cancer goals, PD‑L1-driven therapy choices, and when to intensify with chemo plus dual ...

Significantly, the researchers calculated that the amount needed to treat one patient with pembrolizumab in India could ...

Antonio Ocejo, MD, discusses supportive care implications from new data comparing ipilimumab/nivolumab in older vs younger ...

Rosemary Andrew from Oldham has been living with renal cell cancer since 2022 and is now receiving a faster immunotherapy ...

Rosemary Andrew from Oldham has been living with renal cell cancer since 2022 and is now receiving a faster immunotherapy ...